| Item 1. | |
| (a) | Name of issuer:
Marinus Pharmaceuticals, Inc. |
| (b) | Address of issuer's principal executive offices:
5 Radnor Corporate Center, Suite 500, 100 Matsonford Road, Radnor, Pennsylvania 19087, United States of America |
| Item 2. | |
| (a) | Name of person filing:
Sofinnova Investments, Inc.
Sofinnova BioEquities GP LLC
James Healy
Eric Delbridge |
| (b) | Address or principal business office or, if none, residence:
Sofinnova Investments, Inc.
3000 Sand Hill Road, Building 3, Suite 150
Menlo Park, California 94025
United States of America
Sofinnova BioEquities GP LLC
3000 Sand Hill Road, Building 3, Suite 150
Menlo Park, California 94025
United States of America
James Healy
c/o Sofinnova Investments, Inc.
3000 Sand Hill Road, Building 3, Suite 150
Menlo Park, California 94025
United States of America
Eric Delbridge
c/o Sofinnova BioEquities GP LLC
3000 Sand Hill Road, Building 3, Suite 150
Menlo Park, California 94025
United States of America |
| (c) | Citizenship:
Sofinnova Investments, Inc. - California
Sofinnova BioEquities GP LLC - Delaware
James Healy - United States of America
Eric Delbridge - United States of America |
| (d) | Title of class of securities:
Common Stock, par value $0.001 per share |
| (e) | CUSIP No.:
56854Q200 |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
|
| (b) | Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
|
| (c) | Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
|
| (d) | Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
|
| (e) |  An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
|
| (f) | An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
|
| (g) | A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
| (h) | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
| (i) | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
| (j) | A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
|
| (k) | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
|
| | |
| Item 4. | Ownership |
| (a) | Amount beneficially owned:
Sofinnova Investments, Inc. - 0
Sofinnova BioEquities GP LLC - 0
James Healy - 0
Eric Delbridge - 0 |
| (b) | Percent of class:
Sofinnova Investments, Inc. - 0.0%
Sofinnova BioEquities GP LLC - 0.0%
James Healy - 0.0%
Eric Delbridge - 0.0% |
| (c) | Number of shares as to which the person has:
|
| | (i) Sole power to vote or to direct the vote:
Sofinnova Investments, Inc. - 0
Sofinnova BioEquities GP LLC - 0
James Healy - 0
Eric Delbridge - 0
|
| | (ii) Shared power to vote or to direct the vote:
Sofinnova Investments, Inc. - 0
Sofinnova BioEquities GP LLC - 0
James Healy - 0
Eric Delbridge - 0
|
| | (iii) Sole power to dispose or to direct the disposition of:
Sofinnova Investments, Inc. - 0
Sofinnova BioEquities GP LLC - 0
James Healy - 0
Eric Delbridge - 0
|
| | (iv) Shared power to dispose or to direct the disposition of:
Sofinnova Investments, Inc. - 0
Sofinnova BioEquities GP LLC - 0
James Healy - 0
Eric Delbridge - 0
|
| Item 5. | Ownership of 5 Percent or Less of a Class. |
| |
Ownership of 5 percent or less of a class
|
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. |
| |
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
All of the securities reported in this Schedule 13G Amendment No. 1 are directly owned by advisory clients of Sofinnova Investments, Inc. and/or Sofinnova BioEquities GP LLC. None of those advisory clients may be deemed to beneficially own more than 5% of the Common Stock, par value $0.001 per share. |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
| |
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
Please see Exhibit B attached hereto. |
| Item 8. | Identification and Classification of Members of the Group. |
| |
Not Applicable
|
| Item 9. | Notice of Dissolution of Group. |
| |
Not Applicable
|